2009 Saab 9-7x Awd 4x4 Non Smoker Low Miles Onstar Clean Must Sell No Reserve! on 2040-cars

Auto blog

NEVS Emily GT electric sedan developed by ex-Saab engineers finds a buyer

Even in death, Saab could not rest in peace. In life, the Swedish automaker never managed to get out from between the sales rock and the financial hard place. After GM bought half the company in 1989 and took full control in 2000, the inevitable brand engineering led to cars like a Saab 900 on an Opel platform, a Subaru Impreza rebadged as a Saab 9-2X and a Chevrolet Trailblazer turned into a Saab 9-7x. This went as well as anyone who knew Saab would expect. Come January 2010, Saab was dead. Or rather, Saab had entered a zombie state rebranded as New Electric Vehicle Sweden (NEVS), two Chinese companies in succession buying the automaker's intellectual property, both having to walk away due financial issues at the parent companies. Earlier this year, NEVS showed one of the projects it continued to work on throughout the turmoil, a four-seat battery-electric car called the Emily GT. NEVS said it was looking for a buyer for the project or the entire company. According to Sweden's Auto, Motor und Sport (translated) that broke the story, and further reporting from Saab Planet, the search has succeeded and the Emily will come to life. Saab Planet writes that in March of this year, a Swedish company called Stenhaga Invest bought 80% the the Stallbacka factory and office complex in Trollhattan where Saab used to build its cars, NEVS holding onto the remaining 20%. AMS reported that an as-yet-unknown European investor has signed a letter of intent to purchase two of the 13 projects NEVS said it has been working on, the Emily GT and the PONS, an autonomous shuttle. Svante Andersson, who runs Stenhaga, is reported to have said the unnamed investor is interested in taking control of "a substantial area" of the Trollhattan facilities, "indicating that a significant number of people will be employed in Trollhattan." Back in March, an NEVS engineer said properly funded development could get the Emily GT into production in less than two years. Based on the sports sedan we've been told about, that seems reasonable. Ineos chief Sir Jim Ratcliffe announced the Ineos Automotive Grenadier in 2017, showed a concept in 2020, and had a model running the hill at Goodwood in 2021 — four years for a ground-up design. Saab Planet writes that "a timeline for relaunch is expected to be announced after a meeting between the parties involved during week 32," which would be the week of August 7.

Grainy leaked images show stillborn Castriota-designed Saab 9-3

The Saab faithful are going to be playing the "what if" game for years to come. It's one of the burdens of being a fan of a dead brand. A fresh batch of grainy 9-3 Phoenix images have made their way online, alleged shots of a design proposal penned by none other than Jason Castriota. The five-door looks to feature an honest liftback, though SaabsUnited.com says this particular vehicle was drawn up as part of a business plan in early 2011. As such, Castriota apparently told the site the final product was to look much more athletic than what we see here. While the low-resolution images make it difficult to tell much about the design, we certainly appreciate the familiar roofline, full band taillamps and the contrasting rear spoiler reminiscent of the old Saab 99 and 900 ducktails.
Unfortunately, we know all too well why this creation never saw the light of day. Would-be savior Victor Muller couldn't quite pull Saab out of its nosedive, and the company fell into bankruptcy before the 9-3 Phoenix could get off the ground. There's talk of the Phoenix platform and Saab brand having new life in other markets as EVs and even as gas cars, but the model seen here will likely never see production - let alone North American showrooms.
You can take a closer look at SverigesRadio.se - just make sure to have your translator ready if you don't speak Swedish.

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.